Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AXYS Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: bob zagorin who wrote (317)	10/5/1999 1:24:00 PM
From: bob zagorin	Respond to of 455

made the lead stories on biospace L e a d S t o r i e s Johnson & Johnson (JNJ) And Centocor (CNTO) Announce Stock Conversion Ratio For Proposed $4.9 Billion Merger ------ Axys Advanced Technologies, A Subsidiary Of Axys Pharmaceuticals, (AXPH) Announces Agreement With Allergan (AGN) Worth Approximately $55 Million -- AXPH Stock Up +3.5% On Tuesday At 10:24 AM EST ------ New Studies Show Progenics Pharmaceuticals (PGNX) Drug To Be Potent HIV Inhibitor -- Stock Up +10.5% On Tuesday At 10:52 AM EST ------ Merck & Co. (MRK) Wins U.S. Patent Interference Proceeding On Vioxx ------ Monsanto (MTC) Vows Not To Commercialize Terminator Gene In Seed Research ------ Incyte Pharmaceuticals (INCY) Warns Again That '99 Sales Will Miss Forecasts biospace.com